A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial(†)

AIMS: Clinical trials suggest that intracoronary delivery of autologous bone marrow-derived cells (BMCs) 1–7 days post-acute myocardial infarction (AMI) may improve left ventricular (LV) function. Earlier time points have not been evaluated. We sought to determine the effect of intracoronary autolog...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur Heart J
Auteurs principaux: Choudry, Fizzah, Hamshere, Stephen, Saunders, Natalie, Veerapen, Jessry, Bavnbek, Katrine, Knight, Charles, Pellerin, Denis, Locca, Didier, Westwood, Mark, Rakhit, Roby, Crake, Tom, Kastrup, Jens, Parmar, Mahesh, Agrawal, Samir, Jones, Daniel, Martin, John, Mathur, Anthony
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2016
Sujets:
Clinical Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4712349/
https://ncbi.nlm.nih.gov/pubmed/26405233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv493
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires